FIELD: medicine.
SUBSTANCE: invention concerns chemical-pharmaceutical industry, more specifically to a pharmaceutical composition expressing nootropic activity and cholinomimetic action. There is offered original pharmaceutical composition containing choline alphoscerate as an active ingredient in therapeutically effective amount and pharmaceutically acceptable carriers, differing that as pharmaceutically acceptable carriers it contains macrogol (polyethylene glycol 400) and povidone (Plasdone or collidone). There is also offered method for making thereof that enables making a high-yield end product. The pharmaceutical composition produced by the declared method exhibits minimum by-effects, improved bioavailability and prolonged storage stability.
EFFECT: invention can be used for treatment or prevention of CNS diseases and consequences of craniocereberal injuries.
11 cl, 1 tbl
